To learn more about our sunRIZE Phase 3 preliminary demographic and baseline clinical characteristics, please check out our poster on our website: rezolutebio.com/wp-content/u... #SPES2025
#RZLT #CongenitalHI #raredisease #hyperinsulinism #ersodetug #PedSky #EndoSky #MedSky

Our team was proud to attend the Southern Ped Endo Society Annual Meeting at UAB in Birmingham this past weekend, presenting an encore poster presentation of the preliminary demographic and baseline clinical characteristics from our Phase 3 #sunRIZE trial. #RZLT #SPES2025 #RZLTInAction #CongenitalHI

At #nationalhealthcouncil 2025 science of patient engagement symposium on elevating innovation. Looking forward to speaking tomorrow on the panel on Data at the speed of care: Engineering universal access, patient driven data to inform AI and ML tools. #spes2025